Comparison of QTc and Troponin Levels in ST Elevation MIs Compared with Non-ST Elevation MIs

Nathan Henrie1, Bryan Harvell1, Amy A Ernst1

  • 1From the Department of Emergency Medicine, University of New Mexico, Albuquerque.

Insights

Non-ST elevation myocardial infarctions (NSTEMIs) showed longer corrected QT (QTc) intervals and lower troponin I levels than ST-elevation myocardial infarctions (STEMIs). This finding helps differentiate these critical cardiac events.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Biomarkers

Background:

  • ST-elevation myocardial infarctions (STEMIs) and non-ST-elevation myocardial infarctions (NSTEMIs) are distinct acute coronary syndromes.
  • Differentiating STEMIs from NSTEMIs is crucial for appropriate clinical management and treatment strategies.
  • Previous studies suggest potential differences in electrocardiographic and biochemical markers between STEMI and NSTEMI patients.

Purpose of the Study:

  • To compare corrected QT (QTc) duration and troponin I levels between patients diagnosed with STEMI and NSTEMI.
  • To investigate the hypothesis that QTc duration and troponin I levels are higher in STEMIs compared to NSTEMIs.

Main Methods:

  • A retrospective case-control study design was employed, analyzing data from a 1-year period.
  • Included were all diagnosed STEMIs and a random sample of NSTEMIs, with data extracted from medical records and electrocardiograms.
  • Statistical analyses included chi-squared tests, parametric/nonparametric tests, and logistic regression to identify predictors.

Main Results:

  • A total of 92 STEMIs and 111 NSTEMIs were analyzed, with high interrater reliability (90%).
  • Contrary to the hypothesis, NSTEMI patients exhibited significantly longer QTc intervals compared to STEMI patients.
  • Troponin I levels did not differ significantly on univariate analysis, but logistic regression indicated an association between higher troponin I and STEMI, and longer QTc with decreased odds of STEMI.

Conclusions:

  • NSTEMI patients were found to have longer QTc intervals and lower troponin I levels than STEMI patients.
  • These findings challenge the initial hypothesis and highlight important differences in QTc and troponin I levels between STEMI and NSTEMI.
  • The study underscores the need for careful interpretation of these markers in differentiating myocardial infarction types.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
353
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
590
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
7.2K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
393